Evidence map›Paper›PMID 42577151›Full record

ArticleFrontiers in neurology

Case Report: Paraneoplastic melanoma-associated retinopathy mimicking posterior uveitis.

Syeda Fatima Abid, Muhammad Hammad Khan, Dina Abdelsalam, Safa Ibrahim, Amy C Schefler, Andrew G Lee

Abstract readCase Reports
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Syeda Fatima AbidDepartment of Ophthalmology, King Edward Medical University, Lahore, Pakistan.
Muhammad Hammad KhanDepartment of Ophthalmology, King Edward Medical University, Lahore, Pakistan.
Dina AbdelsalamDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.
Safa IbrahimDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.
Amy C ScheflerDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.
Andrew G LeeDepartment of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Melanoma-associated retinopathy (MAR) is a rare paraneoplastic ocular manifestation of cutaneous or mucocutaneous melanoma. We describe a novel case of MAR that mimicked an inflammatory or infiltrative retinopathy. Patient presentation: A 68-year-old female developed bilateral, painless, floaters over six months with accompanying photopsia. Bilateral posterior uveitis was noted, and bilateral vitrectomies were non-diagnostic for malignancy. A systemic evaluation revealed a subcutaneous lesion on the medial aspect of her right thigh. Biopsy of the lesion was consistent with melanoma. The patient was diagnosed with melanoma-associated retinopathy (MAR). Conclusion and importance: MAR is a vision-threatening paraneoplastic disorder that more commonly arises in patients with an existing diagnosis of melanoma. Most cases of MAR have normal or near normal fundus examinations at onset. Our case is interesting because the fundus presentation mimicked a posterior uveitis and vitrectomy was non-diagnostic. Clinicians should be aware of paraneoplastic MAR and the potential for "masquerade syndrome." Systemic search for underlying neoplasms including occult melanoma or carcinoma is warranted in such cases.

Indexed as

autoimmune retinopathymelanomamelanoma-associated retinopathyposterior uveitisretinopathy

Identifiers

PMID42577151
PMCPMC13453748

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.